Alternative splicing of


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
28 04 2023
Historique:
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: ppublish

Résumé

Granzyme A from killer lymphocytes cleaves gasdermin B (GSDMB) and triggers pyroptosis in targeted human tumor cells, eliciting antitumor immunity. However, GSDMB has a controversial role in pyroptosis and has been linked to both anti- and protumor functions. Here, we found that

Identifiants

pubmed: 37115914
doi: 10.1126/sciimmunol.adg3196
pmc: PMC10338320
mid: NIHMS1914945
doi:

Substances chimiques

Protein Isoforms 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadg3196

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240955
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI139914
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM133658
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB030015
Pays : United States

Références

Immunity. 2019 Jul 16;51(1):43-49.e4
pubmed: 31097341
EMBO J. 2018 Jul 13;37(14):
pubmed: 29898893
Signal Transduct Target Ther. 2021 Feb 24;6(1):78
pubmed: 33623018
Transl Oncol. 2008 Jul;1(2):73-83
pubmed: 18633457
Int J Mol Sci. 2017 Mar 07;18(3):
pubmed: 28272342
Front Immunol. 2023 Jan 18;14:1082165
pubmed: 36742298
Nat Commun. 2023 Jan 4;14(1):61
pubmed: 36599845
Comput Struct Biotechnol J. 2021 Sep 08;19:5149-5159
pubmed: 34589189
Front Cell Dev Biol. 2022 Feb 24;10:813929
pubmed: 35281099
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7858-63
pubmed: 27339137
Oncotarget. 2016 Aug 30;7(35):56295-56308
pubmed: 27462779
Nature. 2017 Jul 6;547(7661):99-103
pubmed: 28459430
Cell. 2021 Jun 10;184(12):3178-3191.e18
pubmed: 34022140
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1128-E1137
pubmed: 28154144
PLoS One. 2014 Mar 27;9(3):e90099
pubmed: 24675552
Cell. 2022 Jan 20;185(2):283-298.e17
pubmed: 35021065
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
J Mol Cell Biol. 2019 Jun 1;11(6):496-508
pubmed: 30321352
Nature. 2023 Apr;616(7957):598-605
pubmed: 36991125
J Virol. 2017 Aug 24;91(18):
pubmed: 28679757
J Hum Genet. 2016 Sep;61(9):793-6
pubmed: 27193219
PLoS One. 2015 Oct 22;10(10):e0141074
pubmed: 26492577
Nat Genet. 2013 Aug;45(8):918-22
pubmed: 23817570
Cell Res. 2016 Sep;26(9):1007-20
pubmed: 27573174
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13132-13137
pubmed: 27799535
Nature. 2021 May;593(7860):607-611
pubmed: 33883744
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Science. 2020 May 29;368(6494):
pubmed: 32299851
Nature. 2023 Apr;616(7957):590-597
pubmed: 36991122
BMC Genomics. 2013 Sep 17;14:627
pubmed: 24044605
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Nature. 2020 Mar;579(7799):415-420
pubmed: 32188940
EMBO J. 2016 Aug 15;35(16):1766-78
pubmed: 27418190
Immunity. 2020 Jul 14;53(1):106-114.e5
pubmed: 32553275
Nature. 2016 Jul 7;535(7610):111-6
pubmed: 27281216
Front Genet. 2022 Jun 27;13:860727
pubmed: 35832190
Cancer Immunol Res. 2021 Jan;9(1):2-7
pubmed: 33397791
Genes Genet Syst. 2010 Feb;85(1):75-83
pubmed: 20410667
Cell Death Differ. 2023 May;30(5):1366-1381
pubmed: 36899106
Nat Commun. 2017 Jan 03;8:14128
pubmed: 28045099
Nat Commun. 2022 May 11;13(1):2609
pubmed: 35545613
Nature. 2018 May;557(7703):62-67
pubmed: 29695864
Exp Hematol. 2005 Oct;33(10):1160-71
pubmed: 16219538
Sci Rep. 2018 Oct 17;8(1):15319
pubmed: 30333560
J Allergy Clin Immunol. 2018 Nov;142(5):1469-1478.e2
pubmed: 29330013
Nat Rev Drug Discov. 2021 May;20(5):384-405
pubmed: 33692549

Auteurs

Qing Kong (Q)

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

Shiyu Xia (S)

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125, USA.

Xingxin Pan (X)

Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, University of Texas at Austin, Austin, TX 78712, USA.

Kaixiong Ye (K)

Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA 30602, USA.
Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.

Zhouyihan Li (Z)

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

Haoyan Li (H)

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

Xiaoqiang Tang (X)

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

Nidhi Sahni (N)

Department of Epigenetics and Molecular Carcinogenesis and Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Quantitative and Computational Biosciences Program, Baylor College of Medicine, Houston, TX 77030, USA.

S Stephen Yi (SS)

Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, University of Texas at Austin, Austin, TX 78712, USA.
Interdisciplinary Life Sciences Graduate Programs (ILSGP) and Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
Oden Institute for Computational Engineering and Sciences (ICES), University of Texas at Austin, Austin, TX 78712, USA.

Xing Liu (X)

Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, 200031, China.

Hao Wu (H)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Michael B Elowitz (MB)

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125, USA.

Judy Lieberman (J)

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

Zhibin Zhang (Z)

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH